Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus

Indinavir is currently used at a fixed dose of 800 mg either three times a day or twice a day in combination with 100 mg of ritonavir. Dosage individualization based on plasma concentration monitoring might, however, be indicated. This study aimed to assess the pharmacokinetic profile of indinavir i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Csajka, Chantal, Marzolini, Catia, Fattinger, Karin, Décosterd, Laurent A., Telenti, Amalio, Biollaz, Jérôme, Buclin, Thierry
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC514769/
https://ncbi.nlm.nih.gov/pubmed/15328077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.9.3226-3232.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares